Life in the fast lane: are digital technologies harming our quality of life?
A new 1.7m multinational research project - TIMED - is led by LJMUs Dr Ruth Ogden, who shared her thoughts with us.
A new 1.7m multinational research project - TIMED - is led by LJMUs Dr Ruth Ogden, who shared her thoughts with us.
On Tuesday 27th & Wednesday 28th August 2019, the MA Art in Science programme at Liverpool School of Art and Design hosted an Art & Science Exchange workshop with members of the Biochemical Society. The exchange was held at the John Lennon Art and Design Building, in the Public Exhibition Space and X-Gallery amongst the MA Art in Science student's end of programme postgraduate exhibition, which showcases the outcomes of their three month research projects. These projects served as a basis for investigation of specific art-science interactions, and were supported by open discussions, hands on activities and a Liverpool LASER talk.
In a bid to better connect students with digital and creative businesses across the Liverpool City Region, Liverpool John Moores University (LJMU) has signed a memorandum of understanding (MoU) with Baltic Creative Community Interest Company (CIC).
This year's conference will take place on Thursday 11 and Friday 12 June and submissions are now invited from staff and students and collaborative partner institutions, as well as other colleagues working in post-16 education.
Celebrating the launch of the Unicaf and LJMU partnership
The university has won accolades for its work with China, as part of the UK's Department for International Trade Greater China Awards 2022.
Liverpool John Moores University has been chosen as the Consortium Secretariat of a new Going Global Partnership, funded by the British Council, with Malaysia. The new collaboration aims to promote strategic engagement and bilateral cooperation in higher education between partner institutions in both countries.
Institute claims top five ranking in UK
"Her interest in technology and digital art respond to the pertinent issues of our time"
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.